Biopharma Focus Kerdan Group is a boutique strategy consulting firm based in Cambridge, MA, with a specific focus on biopharma development and disease areas, presenting opportunities to upsell strategic services to large global biopharma clients seeking external perspectives on asset development, disease area strategy, and proof-of-concept definition.

Established Cred Founded in 2001 and having worked with seven of the top ten global biopharma companies, Kerdan demonstrates credibility and established relationships, suggesting receptive access to decision makers in large pharmaceutical organizations for strategic engagements.

Inspire Prototype Their core methodology inspire-prototype-adapt emphasizes creative, prototyped, and collaborative approaches to drug development challenges, presenting a compelling selling point for clients pursuing innovative, forward-looking strategies to de-risk development and create better options.

Revenue Opportunites With revenue in the range of one to ten million dollars, there is potential to expand engagements through larger multi-project programs, strategic reviews, and ongoing advisory retainers with mid- to large-cap biopharma firms seeking continued external input.

Tech & Data Edge A lightweight tech stack including Cloudflare, Google Tag Manager, and analytics/monitoring tools indicates readiness to leverage data-driven insights and digital collaboration for client projects, which can be offered as value-adds in engagements or as enablement for remote, efficient consulting delivery.